116 related articles for article (PubMed ID: 22210046)
1. Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women.
Izbicka E; Streeper RT; Michalek JE; Louden CL; Diaz A; Campos DR
Cancer Genomics Proteomics; 2012 Jan; 9(1):27-35. PubMed ID: 22210046
[TBL] [Abstract][Full Text] [Related]
2. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.
Blanco-Prieto S; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Vázquez-Iglesias L; Botana-Rial MI; Fernández-Villar A; De Chiara L
BMC Cancer; 2017 Dec; 17(1):823. PubMed ID: 29207990
[TBL] [Abstract][Full Text] [Related]
3. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
4. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
[TBL] [Abstract][Full Text] [Related]
5. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
6. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
[TBL] [Abstract][Full Text] [Related]
7. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
8. Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?
Sotiropoulos GP; Kotopouli M; Karampela I; Christodoulatos GS; Antonakos G; Marinou I; Vogiatzakis E; Lekka A; Papavassiliou AG; Dalamaga M
J BUON; 2019; 24(3):943-954. PubMed ID: 31424646
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
Hou Y; Guo H; Guo Y; Zhang Y; Han H
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
[TBL] [Abstract][Full Text] [Related]
10. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.
Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H
Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354
[TBL] [Abstract][Full Text] [Related]
12. Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
Patnaik SK; Kannisto ED; Mallick R; Vachani A; Yendamuri S
PLoS One; 2017; 12(7):e0181926. PubMed ID: 28742859
[TBL] [Abstract][Full Text] [Related]
13. Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.
Kim YJ; Sertamo K; Pierrard MA; Mesmin C; Kim SY; Schlesser M; Berchem G; Domon B
J Proteome Res; 2015 Mar; 14(3):1412-9. PubMed ID: 25597550
[TBL] [Abstract][Full Text] [Related]
14. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
15. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
16. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
[TBL] [Abstract][Full Text] [Related]
17. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
[TBL] [Abstract][Full Text] [Related]
18. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
[TBL] [Abstract][Full Text] [Related]
19. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
20. Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.
Lococo F; Paci M; Rapicetta C; Rossi T; Sancisi V; Braglia L; Cavuto S; Bisagni A; Bongarzone I; Noonan DM; Albini A; Maramotti S
Int J Mol Sci; 2015 Aug; 16(8):19612-30. PubMed ID: 26295387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]